258264-09-4 Usage
Uses
Used in Organic Synthesis:
2-(6-Amino-pyridin-3-yl)-2-methyl-propionic acid ethyl ester is used as a reagent in organic synthesis for its ability to participate in a variety of chemical reactions, contributing to the formation of new compounds with potential applications in different industries.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-(6-Amino-pyridin-3-yl)-2-methyl-propionic acid ethyl ester is used as a precursor or intermediate in the synthesis of pharmaceuticals, leveraging its unique structural features to create molecules with specific biological activities.
Used in the Synthesis of Complex Molecules:
2-(6-Amino-pyridin-3-yl)-2-methyl-propionic acid ethyl ester serves as a building block in the synthesis of more complex molecules, potentially leading to the development of advanced materials and compounds with specialized functions in various applications.
Used in Chemical Research:
In the realm of chemical research, 2-(6-Amino-pyridin-3-yl)-2-methyl-propionic acid ethyl ester is utilized as a subject of study to explore its properties, reactivity, and potential interactions with other molecules, which can contribute to the advancement of chemical knowledge and the discovery of new applications.
Check Digit Verification of cas no
The CAS Registry Mumber 258264-09-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,8,2,6 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 258264-09:
(8*2)+(7*5)+(6*8)+(5*2)+(4*6)+(3*4)+(2*0)+(1*9)=154
154 % 10 = 4
So 258264-09-4 is a valid CAS Registry Number.
258264-09-4Relevant articles and documents
IMIDAZOPYRIDINES SYK INHIBITORS
-
Paragraph 0355, (2014/06/11)
Certain imidazopyridines (I) and pharmaceutical compositions thereof are provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are provided. Also provided are methods for determining the presence or absence of Syk kinase in a sample.
IMIDAZOPYRIDINES SYK INHIBITORS
-
Page/Page column 60; 62, (2011/10/05)
Certain imidazopyridines (I) and pharmaceutical compositions thereof are provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are provided. Also provided are methods for determining the presence or absence of Syk kinase in a sample.